Evidence map›Paper›PMID 9916105›Full record

ArticleInfection and immunity1999

In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen.

A S MacFarlane, M G Schwacha, T K Eisenstein

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2020
    Review
  3. Anatomy of a discovery: m1 and m2 macrophages.Frontiers in immunology · 2015
    Review
  4. Article
  5. Article
  6. Review
  7. Metabolic host responses to infection by intracellular bacterial pathogens.Frontiers in cellular and infection microbiology · 2013
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tolerance in the absence of autoantigen.Endocrine, metabolic & immune disorders drug targets · 2007
    Review
  15. Article
  16. Salmonella inhibit T cell proliferation by a direct, contact-dependent immunosuppressive effect.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A S MacFarlaneDepartment of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
M G Schwacha
T K Eisenstein
Temple University · US

Funding

TRAINING PROGRAMS IN MICROBIOLOGY &IMMUNOLOGYT32AI007101 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GANEA, DOINA · 1985 to 2008
$2.4M
IMMUNITY TO SALMONELLA INFECTIONR01AI015613 · NIAID · TEMPLE UNIVERSITY · PI EISENSTEIN, TOBY K. · 1985 to 1996
–
NIAID NIH HHS AI15613NIAID NIH HHS T32 AI007101NIAID NIH HHS T32 AI07101
6 · The paper itself

Abstract

Our laboratory has previously shown that after immunization with a strain of Salmonella typhimurium, SL3235, made avirulent by a blockage in the pathway of aromatic synthesis, murine splenocytes were profoundly suppressed in their capacity to mount an in vitro antibody plaque-forming cell (PFC) response to sheep erythrocytes. Evidence indicated that suppression was mediated by nitric oxide (NO), since the in vitro addition of NG-monomethyl-L-arginine blocked suppression. The present studies examined the effect of blocking NO production on Salmonella-induced immunosuppression by in vivo administration of aminoguanidine hemisulfate (AG). AG was administered to C3HeB/FeJ mice in their drinking water (2.5% solution) for 7 days prior to intraperitoneal inoculation with SL3235. AG treatment inhibited the increase in nitrate and nitrite levels in plasma and nitrite levels in the spleen seen in immunized mice. Importantly, AG treatment completely blocked suppression of the splenic PFC response and markedly attenuated the suppression of the response to concanavalin A in immunized mice, providing further evidence that Salmonella-induced immunosuppression is mediated by NO. AG treatment also alleviated the majority of the splenomegaly associated with SL3235 inoculation, which correlated with a blockage of influx of neutrophils and macrophages into spleens, as assessed by flow cytometry. AG treatment unexpectedly resulted in 90% mortality in mice injected with the highly attenuated vaccine strain of Salmonella, SL3235. Increased mortality in AG-treated mice correlated with inability to clear organisms from the spleen by day 15 postinoculation and with persistent bacteremia, compared with control mice. Collectively, these in vivo results underscore the dual biological consequences of NO production following Salmonella infection, with NO being necessary for host defense, but also having the potentially adverse effect of immunosuppression. A unifying hypothesis to explain how these seemingly paradoxical effects could both result from NO production is presented.

Indexed as

AnimalsEnzyme InhibitorsFemaleGuanidinesImmune ToleranceMacrophagesMiceMice, Inbred C3HNeutrophilsNitratesNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitritesSalmonella Infections, AnimalSalmonella typhimuriumEnzyme InhibitorsGuanidinesNitratesNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitritesNos2 protein, mousepimagedine

Identifiers

PMID9916105
PMCPMC96401
OpenAlexW2143660954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.